Evidence map›Paper›PMID 32643269›Full record

ArticleJournal of diabetes investigation2021

Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.

Tomohito Gohda, Nozomu Kamei, Mitsunobu Kubota, Kanako Tanaka, Yoshinori Yamashita, Hiroko Sakuma, Chiaki Kishida, Eri Adachi, Takeo Koshida, Maki Murakoshi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Tomohito GohdaDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0513-4433
Nozomu KameiDepartment of Endocrinology and Metabolism, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Mitsunobu KubotaDepartment of Endocrinology and Diabetology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Kanako TanakaDepartment of Endocrinology and Diabetology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Yoshinori YamashitaInstitute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Hiroko SakumaDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Chiaki KishidaDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Eri AdachiDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Takeo KoshidaDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Maki MurakoshiDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Shinji HagiwaraDepartment of Kidney and hypertension, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
Kazuhiko FunabikiDepartment of Kidney and hypertension, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
Seiji UedaDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Yusuke SuzukiDepartment of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Juntendo University · JPNational Hospital Organization · JPTokyo Metropolitan Geriatric Hospital · JPHiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital · JP

Funding

Japan Society for the Promotion of Science 17K09711Japan Society for the Promotion of Science 20K08617
6 · The paper itself

Abstract

AIMS/

introductionIncreased concentrations of serum tumor necrosis factor (TNF) receptors (TNFRs; TNFR1 and TNFR2) are positively associated with the urinary albumin-to-creatinine ratio (ACR), and negatively associated with the estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes. However, the mechanism underlying this increase and the relationship between TNFRs in serum, and urine and kidney measures (ACR and eGFR) are unclear. MATERIALS AND

methodsThis was a cross-sectional study that included 499 patients with type 2 diabetes and eGFR ≥60 mL/min/1.73 m

resultsSerum and urinary TNFR levels were positively associated with the ACR, and negatively associated with the eGFR. The fractional excretion of TNFRs did not differ between patients with an eGFR ≥90 and those with an eGFR 60-89 mL/min/1.73 m

conclusionsThe pattern of fractional excretion TNFRs showed that an increase in serum TNFRs might result from their increased systemic production, including in the kidney, rather than being a simple reflection of GFR decline. Kidney measures appear to be strongly associated with serum TNFRs rather than urinary TNFRs in patients with type 2 diabetes and normal renal function.

Indexed as

AgedCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateHumansKidneyKidney Function TestsMaleMiddle AgedReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITNFRSF1A protein, humanTNFRSF1B protein, humanBiomarkerDiabetic kidney diseaseTumor necrosis factor receptor

Identifiers

PMID32643269
PMCPMC7926211
OpenAlexW3042124442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.